Cite
HARVARD Citation
David, C. et al. (2020). Soluble CD163 is a biomarker for accelerated atherosclerosis in systemic lupus erythematosus patients at apparent low risk for cardiovascular disease. Scandinavian journal of rheumatology. pp. 33-37. [Online].